Constant vs Varied-Frequency EMS, What Fatigue Studies Show
Medically reviewed by
4 independent reviewers
Andrew Conrad Barile, PT, DPT
Doctor of Physical Therapy (DPT) | Licensed Physical Therapist (PT) | CEO and Founder, Xtreem Pulse LLC
Read bio
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC, the engineering company behind PureLift. He earned his Doctorate in Physical Therapy from Daemen College and is a licensed physical therapist.
He brings over two decades of clinical and entrepreneurial experience across physical therapy, craniosacral therapy and medical device innovation, built on a working knowledge of human anatomy and muscle physiology.
For PureLift LAB he reviews how current is delivered across all ten levels, from sub-sensory nanocurrent and skin-level microcurrent to motor-level EMS, and how the Infuse pass fits into the same ten-minute routine.
Bertica M. Rubio, M.D.
Board-Certified Physician, Dartmouth Medical School | Medical Director, Antiaging Regenerative Medicine Clinic
Read bio
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Doctor of Medicine from Dartmouth Medical School and completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, she specialises in age management medicine, regenerative medicine, wound healing and growth factor therapies, and her practice integrates evidence-based medical science with advanced aesthetic treatment.
For PureLift LAB she reviews articles for medical accuracy across the whole dial, from the gentle nanocurrent and microcurrent settings through to muscle-level EMS and the Infuse pass.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist | Head and Neck Surgeon | Fellow, American College of Surgeons | Mount Sinai
Read bio
Daniel Grinberg, MD, FACS is a board-certified otolaryngologist and head and neck surgeon at ENT and Allergy Associates in West Nyack, New York. He earned his medical degree from Columbia University College of Physicians and Surgeons.
He completed his otolaryngology residency at New York University Medical Center, serves as Assistant Clinical Professor at Mount Sinai School of Medicine, and is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
For PureLift LAB he brings a wider clinical lens, connecting at-home facial stimulation from microcurrent to EMS to the anatomy underneath, with the same rigour we apply to every device specification.
Prof. Dr. med. Ivo Buschmann
Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology
Read bio
Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital.
He trained at the University of Hamburg, was a Max Planck Society Fellow at the Max Planck Institute for Heart and Lung Research, and held senior consultant posts at the Charite Universitatsmedizin Berlin before his appointment as Chair in 2016.
One of Europe's leading authorities on arteriogenesis, with over 150 peer-reviewed publications and US and EU patents, he reviews for PureLift LAB how the evidence on electrical stimulation is read and where its limits lie.
Share
A fixed signal costs you something you cannot see, because the session fades across its own ten minutes while the device keeps delivering exactly what it started with.
This article covers what the fatigue research shows, such as:
- What accommodation is, and why you cannot feel it happening
- What the pooled studies actually measured
- The study that disagrees, and why we cite it
- What this does and does not mean for your face
- Why turning the dial up is the wrong fix
and many more!
By the end you will understand a real engineering difference and its honest limits.
Key Points:
Muscle and nerves both adapt to a repeated signal, so a session can fade while the output stays identical.
Pooling 22 studies, researchers found stimulation that keeps changing produced more evoked force with less fatigue than a fixed pattern.
One study found variable trains tired muscle as much as constant ones, and we cite it rather than leaving it out.
This research measured force and fatigue in muscle, not cosmetic outcomes on a face.
The honest claim is that varying the frequency is designed to reduce accommodation, not that it prevents it.
This is the most technical argument in facial devices and one of the few with genuine research behind it, so it is worth setting out properly rather than as a slogan.
What accommodation is
Send a muscle the same fixed signal repeatedly and the response to that signal declines, because both the muscle and the nerves driving it adapt to a predictable input.
The device has not changed anything, the output is identical at minute nine to what it was at minute one, and the effect has quietly diminished.
You experience it as the session fading, which most people interpret as the device weakening or their skin getting used to it.
The reason it matters is that a ten-minute session is long enough for this to happen within a single sitting.
What the pooled research found
Pooling 22 studies, researchers found that stimulation which keeps changing produced more evoked force with less fatigue than a fixed pattern (Cavalcante 2026).
A randomised crossover trial found that varying the frequency reduced how quickly people habituated to stimulation (Avendano-Coy 2019).
Those two findings are the foundation of the varied-frequency argument, and they are about the pattern of the signal rather than its strength.
The work behind this approach also found frequency variation more effective than pulse-duration variation at changing how quickly fatigue sets in, and found that benefit independent of amplitude, which is why frequency is the variable worth moving.
The study that disagrees
One study found variable trains tired muscle as much as constant ones (Papaiordanidou 2014).
We cite it in every article that makes this argument, because a body of evidence with a dissenting result is what real evidence looks like, and leaving it out would make the case look stronger than it is.
What it means practically is that the effect is supported rather than settled, and that the honest claim has to be narrower than the marketing version.
Any brand presenting this as proven fact has either not read the literature or has decided you will not.
What this research did not measure
These studies measured evoked force and fatigue in muscle under controlled stimulation, which is a laboratory question rather than a cosmetic one.
None of them measured a face, a wrinkle, a jawline or a photograph.
So it is legitimate to cite them for the engineering claim, that varying the frequency addresses accommodation, and it is not legitimate to cite them for a cosmetic claim about lifting or firming.
Borrowing evidence from one question to answer another is the commonest sleight of hand in this category, and we try not to do it.
What supports the cosmetic side separately
In the largest facial trial of its kind, 108 women used daily muscle stimulation for twelve weeks and ultrasound measured an 18.6 percent increase in cheek-muscle thickness, with a clear difference from the untreated group at six weeks (Kavanagh 2012).
A double-blind, sham-controlled trial in adults over 65 found muscle thickness and bite force increased after six weeks (Chang 2020).
Those are the studies that support facial muscle stimulation as a technology, and they are category studies run with their own devices rather than tests of any product.
Two separate evidence bases, two separate claims, kept apart.
How PDM applies it
PDM, the delivery architecture inside every PureLift, moves the signal across 361 frequency points between 1,370 and 1,730 Hz so it does not repeat.
Frequency is the only variable it changes, since amplitude stays exactly where you set it rather than drifting while you work.
What that changes for you is the consistency of the session rather than its strength, so if level 5 felt right at minute one it should feel about the same at minute nine.
No randomised trial has compared a PureLift against any fixed-frequency device, so the case rests on the category research and the engineering rather than on a measured win.
Why turning the dial up is the wrong fix
When a session fades, the instinctive response is more output, and that treats a pattern problem as a power problem.
A review of kilohertz-frequency stimulation describes three separate thresholds in everyone, the point you feel the current, the point the muscle moves, and the point it hurts (Ward 2009), and pushing past the second one moves you toward the third without adding benefit.
The better checks are your serum coverage, your contact and your placement, since those change the delivered current far more often than the device does.
Add serum before you reach for the dial, every time.
Model notes
All five PureLift models run nanocurrent at level 1, microcurrent at level 2, EMS from level 3 to 10, and Infuse as a second pass, and all five carry PDM with the same 361 frequency points.
So the delivery architecture is identical across the range, and what differs is the top of the dial.
Face at $499 and Pro at $699 reach up to 7 milliamps, Pro Edition at $799 reaches up to 7.7, and Pro Plus + at $899 and GLOW at $999 reach up to 9, all measured at 500 ohms and always written as up to.
The session is three minutes on each side of the face, about ten minutes including the Infuse pass.
GLOW alone adds light, red at 634 nm cleared for the treatment of wrinkles, blue at 465 nm cleared for mild-to-moderate inflammatory acne, and purple, which is red and blue running together.
Every model is cleared through the FDA 510(k) pathway, under records K190269 for Face, K230506 for Pro and Pro Edition, K221443 for Pro Plus + and K243587 for GLOW, and all five are made in Japan in an ISO 13485 facility.
Anyone with a pacemaker or another implanted electronic device, anyone pregnant, and anyone with epilepsy or a seizure disorder should not use the device at all.
For the engineering history, read smarter power, and for why a device that feels stronger is not better, read stronger-feeling devices.
Model figures verified on 9 September 2026 against the PureLift LAB store and FDA records K190269, K230506, K221443 and K243587. Every model runs nanocurrent, microcurrent, EMS and Infuse; consumer copy always says up to.
Two related questions come up often alongside this one, and we have answered both in full: why these devices are almost certainly not FSA or HSA eligible, and the honest cost benefit arithmetic.